THBS1 and neoplasm: There is evidence from mouse tumor models and clinical trials that MC decreases the levels of proangiogenic factors and increases the levels of endogenous angiogenesis inhibitors, such as trombospondin-1 (TSP-1), which may contribute to the angiogenic dormancy of the primary tumor [86].